BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V903. A total of 4 filers reported holding BIOCRYST PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,819,000 | – | 550,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 772,100 | $6,439,314 | 0.02% |
| JANE STREET GROUP, LLC | 187,000 | $1,559,580 | 0.00% |
| SIMPLEX TRADING, LLC | 151,200 | $1,261 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |